GlassScriptPhysician profile
Mary M Wilcox
NPI 1144742313
$2,842.33
in general payments reported to CMS, 2019-2025
34 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $999 · 2022: $700 · 2023: $288 · 2024: $398 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $445.18 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $308.33 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $232.15 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $181.84 | 2021 | |
| Amgen INC. | $163.46 | 2021-2024 | Krystexxa |
| Si-Bone, INC. | $130.73 | 2021 | |
| Eisai INC. | $125.89 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.90 | 2022 | |
| Corcept Therapeutics | $111.58 | 2022 | |
| Sunovion Pharmaceuticals INC. | $106.94 | 2021 | |
| Phathom Pharmaceuticals, INC. | $96.48 | 2025 | Voquezna |
| Inspire Medical Systems, INC. | $80.49 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $79.31 | 2022-2024 | |
| Philips North America LLC | $69.91 | 2022 | |
| Exact Sciences Corporation | $63.88 | 2023-2025 | Cologuard Collection Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $63.68 | 2022 | |
| Lundbeck LLC | $52.59 | 2021 | |
| Viiv Healthcare Company | $45.07 | 2024-2025 | Cabenuva |
| Otsuka America Pharmaceutical, INC. | $41.78 | 2021 | |
| Nevro Corp. | $33.00 | 2022 | |
| Medtronic, INC. | $32.54 | 2022 | |
| Hologic Sales and Service, LLC | $31.51 | 2025 | Aptima |
| Emd Serono, INC. | $28.38 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.91 | 2022 | |
| Tactile Systems Technology INC | $20.00 | 2022 | |
| Pfizer INC. | $19.88 | 2025 | |
| Tris Pharma INC | $18.98 | 2025 | Onyda Xr |
| Cardiovascular Systems INC. | $17.49 | 2022 | |
| Vanda Pharmaceuticals INC. | $16.88 | 2021 | |
| Gilead Sciences, INC. | $16.61 | 2021 | |
| Almatica Pharma LLC | $16.47 | 2021 | |
| Neurocrine Biosciences, INC. | $14.92 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.91 | 2021 | |
| Corium, LLC | $14.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.